November 21, 2022 at 3:00 pm

Lexaria Bioscience Turns Focus to Dementia and Diabetes with New Studies

Lexaria Bioscience (Nasdaq): LEXX is investigating the potential therapeutic utility of its proprietary DehydraTECHTM-CBD against dementia and diabetes, two of the world’s biggest public health crises. The global dementia drug market is projected to reach $32.3 billion by 2030 diabetes and the diabetes drug market is expected to reach $82.92 billion by 2027. Lexaria recently demonstrated… [Read More]
November 17, 2022 at 9:37 pm

Lightning eMotors (ZEV) Drops 40% As Company Enters into Exchange Agreement with Convertible Noteholders

Lightning eMotors (ZEV) an electric vehicles company fell 40% in a rough day for EV stocks. The drop also comes shortly after the Company announced they are entering into exchange agreements with certain 7.5% convertible noteholders. The Company exchanged 13.3 million newly issued shares of common stock for $14M aggregate principal amount of the Convertible… [Read More]
November 17, 2022 at 9:40 am

Asensus Surgical Leases SenhanceⓇ Surgical System to 9th German Hospital; First Pediatric Surgery Program

  Medical device company, Asensus Surgical (NYSE American: ASXC) has announced the first-ever Senhance pediatric surgery program will be initiated by a children’s hospital in Germany. The Dr. von Hauner Children’s Hospital at Ludwig Maximilians University, Munich, has entered into an agreement to lease and utilize a Senhance Surgical System. Highlights Asensus’ Senhance Surgical System… [Read More]
November 16, 2022 at 12:27 am

Exagen (XGN) Skyrockets 42% After Q3 Earnings Report

Exagen (XGN) , a medical diagnostic company, skyrocketed 42% the day after posting their Q3 earnings report. Exagen reported a quarterly loss of $0.47 per share versus the Zacks Consensus of a loss of $0.76 per share. Exagen also posted revenue of $14.73 million beating the Zacks Consensus Estimate by 61.24%. “I’m very excited to… [Read More]
November 11, 2022 at 11:27 am

Bionik Laboratories Q2 Fiscal Year 2023 Earnings: New Strategic Direction Increases Outlook for Growth; Revenue Increase of 113% YoY

  Robotics company, Bionik Laboratories Corp. (BNKL) has announced its earnings for the second quarter of fiscal year 2023, reporting a revenue increase of 113% and subscription revenue increase of 10% YoY. In September, the company began a nationwide roll-out of a network of neuro-recovery Centers of Excellence that will showcase Bionik technology and solutions…. [Read More]
November 10, 2022 at 2:45 pm

Lexaria Bioscience Initiates Studies Investigating DehydraTECHTM-CBD as a Potential Therapeutic for Dementia and Diabetes

Drug delivery innovator, Lexaria Bioscience (NASDAQ: LEXX) believes its proprietary drug delivery technology, DehydraTECH processed with cannabidiol (CBD) may have applications in the treatment of dementia and diabetes. Lexaria has previously demonstrated the safety and efficacy of DehydraTECH-CBD in human hypertension studies, and has initiated two new studies to investigate the effect of the compound… [Read More]
November 10, 2022 at 1:13 pm

Quoin Pharmaceuticals Announces Third Quarter 2022 Financial Results and Sees 18% Stock Growth

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical stage pharmaceutical company focused on rare and orphan diseases, announced its third-quarter financial results and the market responded—the company’s stock rose 18% percent premarket. Investors are noting how the specialty pharma is executing on its stated goals and that the company is well on track to deliver the… [Read More]
November 10, 2022 at 8:58 am

FDA Clearance For ClearPoint Neuro Laser Device

Global therapy-enabling platform company, ClearPoint Neuro (Nasdaq: CLPT) has been granted FDA 501(k) clearance for a laser it intends to commercialize worldwide. The laser will be marketed as the ClearPoint Prism™ Neuro Laser Therapy System and is being hailed as a “new innovation in the space of laser interstitial thermal therapy”. Laser ablation offers minimally-invasive… [Read More]
November 10, 2022 at 1:44 am

Centrus Energy Corp (LEU) Falls 31% As PRISM Uranium Index Tumbles

Centrus Energy Corp (NYSE American: LEU) fell 31% for the day, as the PRISM Uranium Index tumbled 8.3%, the sharpest fall of all the PRISM Indexes. LEU is not alone, as every Uranium stock in the index was negative. The downturn for LEU also follows a Q3 loss and lagging revenue estimates, posting an earnings… [Read More]
November 09, 2022 at 10:46 am

Biotricity Increases Patient Access to Cardiovascular Care with Launch of Biocare Cardiac

Biotricity Increases Patient Access to Cardiovascular Care with Launch of Biocare Cardiac  Medical diagnostic and consumer healthcare technology provider, Biotricity, Inc., Nasdaq (BTCY) has launched a first-of-its-kind cardiac disease management solution that allows patients to be monitored remotely. The program combines diagnostics, disease and lifestyle management and telemedicine and enables patients to engage with their… [Read More]